Adipsin as a novel prognostic biomarker for cardiovascular diseases

dc.authoridAskin, Lutfu/0000-0001-7768-2562;
dc.authorwosidAskin, Lutfu/H-1047-2018
dc.authorwosidAskin, Husna/JLK-8251-2023
dc.contributor.authorAskin, Lutfu
dc.contributor.authorAskin, Husna Sengul
dc.contributor.authorAbus, Sabri
dc.contributor.authorHidayet, Siho
dc.date.accessioned2024-08-04T20:51:47Z
dc.date.available2024-08-04T20:51:47Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIncreased vascular oxidative stress stimulates the secretion of adipokines from adipocytes. Many clinical studies have demonstrated that plasma adipsin levels are successful in predicting ischemic events. Increased adipsin levels are closely related to all-cause death and morbidity. Therefore, adipsin may be a new biomarker for atherosclerosis. In this review, we aimed to emphasize the association of adipsin with cardiovascular diseases (CVDs) and its beneficial role in the therapeutic field of CVDs.en_US
dc.identifier.doi10.33678/cor.2021.086
dc.identifier.endpage37en_US
dc.identifier.issn0010-8650
dc.identifier.issn1803-7712
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85126723998en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage34en_US
dc.identifier.urihttps://doi.org/10.33678/cor.2021.086
dc.identifier.urihttps://hdl.handle.net/11616/100551
dc.identifier.volume64en_US
dc.identifier.wosWOS:000767371600006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherCzech Soc Cardiology & Czech Soc Cardiovascular Surgeryen_US
dc.relation.ispartofCor Et Vasaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdipsinen_US
dc.subjectAtherosclerosisen_US
dc.subjectCardiovascular diseaseen_US
dc.titleAdipsin as a novel prognostic biomarker for cardiovascular diseasesen_US
dc.typeReview Articleen_US

Dosyalar